One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients.
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2011
At a glance
- Drugs Alpha adrenergic receptor antagonists; Dutasteride
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 20 Jul 2011 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 20 Jul 2011 Actual initiation date (May 2006) added as reported by ClinicalTrials.gov.